LY4064912
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 15, 2026
YHAA: A Study of LY4064912 in Healthy Participants and With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=77 | Terminated | Sponsor: Eli Lilly and Company | N=144 ➔ 77 | Active, not recruiting ➔ Terminated; Sponsor Decision
Enrollment change • Trial termination • Genetic Disorders • Obesity
August 19, 2026
YHAA: A Study of LY4064912 in Healthy Participants and With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=144 | Active, not recruiting | Sponsor: Eli Lilly and Company | Recruiting ➔ Active, not recruiting
Enrollment closed • Genetic Disorders • Obesity
September 04, 2025
YHAA: A Study of LY4064912 in Healthy Participants and With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=144 | Recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Genetic Disorders • Obesity
1 to 3
Of
3
Go to page
1